Sonoma Pharmaceuticals, Inc.

SNOA · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$5,374$3,128$3,820$7,396
Short-Term Investments$0$0$0$0
Receivables$3,763$5,994$2,572$2,407
Inventory$2,915$2,719$2,858$2,663
Other Curr. Assets$596$707$4,548$3,964
Total Curr. Assets$12,648$12,548$13,798$16,430
Property Plant & Equip (Net)$309$651$906$879
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$589$1,145$949$829
Other NC Assets$147$396$578$707
Total NC Assets$1,045$2,192$2,433$2,415
Other Assets$0$0$0$0
Total Assets$13,693$14,740$16,231$18,845
Liabilities
Payables$953$607$841$1,641
Short-Term Debt$278$521$687$1,058
Tax Payable$0$4,710$4,235$3,838
Deferred Revenue$641$478$160$1,277
Other Curr. Liab.$2,224-$2,597-$2,206-$1,995
Total Curr. Liab.$4,096$3,719$3,717$5,819
LT Debt$27$87$162$309
Deferred Rev, NC$17$87$140$182
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$5,142$4,710$4,235$3,838
Total NC Liab.$5,186$4,884$4,537$4,329
Other Liabilities$0$0$0$0
Cap. Leases$85$285$418$559
Total Liabilities$9,282$8,603$8,254$10,148
Equity
Pref Stock$0$0$0$0
Common Stock$0$2$5$2
Retained Earnings-$197,806-$194,349-$189,514-$184,363
AOCI-$4,376-$2,723-$3,418-$4,312
Other Equity$206,593$203,207$200,904$197,370
Total Equity$4,411$6,137$7,977$8,697
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$13,693$14,740$16,231$18,845
Net Debt-$5,069-$2,520-$2,971-$6,029
Sonoma Pharmaceuticals, Inc. (SNOA) Financial Statements & Key Stats | AlphaPilot